发明名称 Priming solutions for cardiopulmonary bypass
摘要 The present invention relates to priming solutions used during cardiopulmonary bypass procedures. In particular, the present invention relates to a cardiopulmonary bypass priming solution comprising a balanced salt solution and a combination of oncotic and non-oncotic dextran molecules. The present invention also relates to the use of the priming solution in a cardiopulmonary bypass method, a method of maintaining oncotic pressure in a patient during a cardiopulmonary bypass procedure, and a combination of cardiopulmonary bypass priming solution and cardiopulmonary bypass apparatus.
申请公布号 US8969323(B2) 申请公布日期 2015.03.03
申请号 US201113634934 申请日期 2011.11.07
申请人 XVIVO Perfusion AB 发明人 Steen Stig
分类号 A61K31/721;A61K31/191;A61K33/14;A61K9/00;A61K9/06 主分类号 A61K31/721
代理机构 Pearne & Gordon LLP 代理人 Pearne & Gordon LLP
主权项 1. A method of maintaining oncotic pressure in a patient during a cardiopulmonary bypass procedure, comprising contacting the patient, during the cardiopulmonary bypass procedure, with a cardiopulmonary bypass priming solution comprising a balanced salt solution and a combination of an oncotic dextran and a non-oncotic dextran, wherein the oncotic dextran provides a functional oncotic pressure corresponding to 35 to 55 g/l of Dextran 40.
地址 Göteborg SE